EU ‘Ready To Approve’ COVID-19 Vaccine On 23 December
Commission Negotiating Vaccine Contract Disclosure With Companies
European parliamentarians have defended the formal marketing authorization approach being taken by the EU, saying “safety is of the utmost importance” if there is to be trust in coronavirus vaccines.
You may also be interested in...
The first COVID-19 vaccine will shortly be available to the EU member states, after the European Commission today approved Pfizer/BioNTech's BNT162b2 just hours after the European Medicines Agency issued a positive opinion on the product. The EMA says that uncertainties remain over the ability of the vaccine to prevent transmission of the coronavirus and whether the new variant strain will render this and other vaccines less effective.
This week has seen two key decisions by the European Medicines Agency designed to speed up the availability of COVID-19 vaccines in the EU.
Resurgence of the coronavirus across Europe made the approval of Pfizer/BioNTech vaccine and the start of immunization programs more urgent.